about
sameAs
Personalised care planning for adults with chronic or long-term health conditionsDecision aids for people facing health treatment or screening decisionsInterventions for improving communication with children and adolescents about a family member's cancerDecision aids for people facing health treatment or screening decisionsDeveloping a quality criteria framework for patient decision aids: online international Delphi consensus process.The requirement for prior consent to participate on survey response rates: a population-based survey in GrampianA centralised public information resource for randomised trials: a scoping study to explore desirability and feasibilityEvaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyValuing patients' experiences of healthcare processes: towards broader applications of existing methods.Vaginal birth after caesarean section: why is uptake so low? Insights from a meta-ethnographic synthesis of women's accounts of their birth choicesFinancial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative studyThe TRIO Framework: Conceptual insights into family caregiver involvement and influence throughout cancer treatment decision-making.Interventions for providers to promote a patient-centred approach in clinical consultations.A meta-ethnography of organisational culture in primary care medical practice.Decision aids for patients facing health treatment or screening decisions: systematic review.Sharing outcomes information with consumers: a new course for health librarians."Was that a success or not a success?": a qualitative study of health professionals' perspectives on support for people with long-term conditionsProtocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they wProtocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they weThe information and support needs of patients discharged after a short hospital stay for treatment of low-risk Community Acquired Pneumonia: implications for treatment without admissionWhat is an adequate sample size? Operationalising data saturation for theory-based interview studies.Health in the 'hidden population' of people with low literacy. A systematic review of the literature.Barriers and facilitators to smoking cessation in a cancer context: A qualitative study of patient, family and professional views.Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.A patient led NHS: managing demand at the interface between lay and primary careSharing decisions with patients: is the information good enough?Patient choice modules for summaries of clinical effectiveness: a proposal.Supporting patient autonomy: the importance of clinician-patient relationshipsShared decision making: trade-offs between narrower and broader conceptionsThe potential contribution of decision aids to screening programmes.What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agenciesDeveloping a placebo-controlled trial in surgery: issues of design, acceptability and feasibilityHow the stigma of low literacy can impair patient-professional spoken interactions and affect health: insights from a qualitative investigationDiscussing wisdom teeth with patients: a critique of information materials.Informing, communicating and sharing decisions with people who have cancerGeneral Practitioners' Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative StudyRegulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study.Marketing and clinical trials: a case study.Patient involvement in treatment decision-making: the case for a broader conceptual framework.Media coverage of the Child B case.
P50
Q24187433-5E335D79-DDFE-4E78-9068-7599BBF65B0DQ24239885-F3EEDE52-C298-4EFB-B725-F592A0EC8CF1Q24247768-3056211F-3131-421A-AEC1-EB38DD21F999Q24250303-3E870186-6592-45A4-97CE-F936C7AE7DD5Q24250303-A5A1CCF7-2CE2-40EE-A21F-78EE6A2446AFQ24672424-0A9179FF-A387-4D04-AB7B-9DB988544E9DQ24672424-1DC87783-8BC0-440C-BF81-62E10CE44E3BQ24799807-61EC1D0B-74BF-4B95-A3BA-87235F4DAF65Q24815109-90C8AC3D-19EA-4A16-839C-0089EA552467Q26778351-7C7D4963-2507-4271-91B8-CA78DE02AC9CQ27691635-FAA48534-7210-4594-B523-15AF7D8BDAE0Q28075502-BB6F306C-C497-4A39-AFD2-251237CF882CQ28763783-7637D517-F438-4A84-91E6-340A34670CADQ30234341-98FBED2A-0682-4211-B046-DC272A00BD8CQ30329165-F6188CDA-521F-4DF7-9EF3-25ABA2EBDA89Q30361942-899C64F7-774D-492A-A66A-02B046D58DA1Q30493146-E79966B5-E820-4F46-BC71-22CE751EA726Q30660763-B6504659-D0DC-473C-B205-38E98603EF12Q30842518-F82F437A-3347-4DFB-BDBA-2C4ABC7026F4Q33246170-EAC4AA36-47CB-4EF1-BD44-FE3582C37424Q33338671-BF5C0840-1A21-4FDD-A064-39BCA5E68472Q33355839-39D80954-A078-48E8-9FDC-5853436D70E4Q33537260-A648D628-238B-4AB8-8A97-0B5D2AF13841Q33650390-C0CA23D2-7AA5-452F-8362-F4B7A64CDD4AQ33709241-BFC5D64D-2C03-4BC0-858F-DA8E93914358Q33764230-8C226C2B-B74F-455D-B329-3E295E6F5FEFQ33790551-7FBA3C21-CE5B-4BE0-8C52-DD9A0D9624CFQ33793584-4CD355B6-4904-48C6-9A3B-7EF29A821D90Q33804535-4AC8CDC6-1727-4A4E-9328-29C73490C8A3Q33898754-E8484AAA-D1BB-4039-88B3-5376F81107EEQ34185877-2746F124-CB08-4B38-80F6-931A331964FAQ34255340-1A79A939-AE46-426D-80A4-25259A594631Q34511939-AEB21E8A-349B-42C1-9C5D-CDB41DA75436Q34639262-19F8B305-9270-4D64-B78D-00A5482264ABQ34956363-EDA4E868-DB31-4534-ACED-A96D80083396Q35094398-3ACC99BB-7E04-4939-A4D0-EA52FE82C91DQ35523506-13F890CE-AA86-4F32-BE62-4AF21EEFB793Q35995860-B492245F-B428-4BFF-82F9-4DBE7DDF1DDDQ36174876-BE21F09A-AA7C-4102-B0B8-FD9E5C0695FEQ36402162-66DF9392-2B40-4942-AED4-F9D12814E5D7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vikki A Entwistle
@es
Vikki A. Entwistle
@en
Vikki A. Entwistle
@nl
Vikki Entwistle
@fr
Vikki Entwistle
@it
Vikki Entwistle
@sl
type
label
Vikki A Entwistle
@es
Vikki A. Entwistle
@en
Vikki A. Entwistle
@nl
Vikki Entwistle
@fr
Vikki Entwistle
@it
Vikki Entwistle
@sl
altLabel
Vikki Entwistle
@en
Vikki Entwistle
@es
prefLabel
Vikki A Entwistle
@es
Vikki A. Entwistle
@en
Vikki A. Entwistle
@nl
Vikki Entwistle
@fr
Vikki Entwistle
@it
Vikki Entwistle
@sl
P106
P1153
7007134373
P21
P31
P496
0000-0002-0856-4025
P569
2000-01-01T00:00:00Z